Healthy Skepticism Library item: 2382
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Hall TS.
Reimagining the learned intermediary rule for the new pharmaceutical marketplace.
Seton Hall Law Rev 2004; 35:(1):193-261
Abstract:
For the past decade, the learned intermediary rule—the rule of tort law that provides that drug manufacturers may satisfy their duty to warn of a drug’s dangers by warning the prescribing physician rather than the end user of the drug—has been the subject of vigorous academic debate. That debate has been largely moot, however, as the courts have proven reluctant to make significant inroads on the protection offered by the Rule to drug manufacturers. This Article proposes a new approach to the Rule. Part I discusses the history and overwhelming adoption of the Rule pursuant to the Restatement (Second) of Torts. Part II argues that changes in the health care delivery system have resulted in a legal system that introduces market distortions by effectively immunizing the pharmaceutical industry from the legal and social consequences of its own actions. Part III then sets forth a reconceptualization of the Rule, which preserves the Rule’s benefits with respect to the drug industry, the health care system, and the goals of tort law, while also strengthening the protection the tort system offers to individuals injured by prescription drugs.
Keywords:
MeSH Terms:
Advertising/legislation & jurisprudence
Consumer Participation
Contraceptives, Oral
Drug Industry/legislation & jurisprudence*
Duty to Warn/legislation & jurisprudence*
Ethics, Medical
Humans
Legislation, Drug*
Liability, Legal*
Life Style
Marketing of Health Services/legislation & jurisprudence*
Mass Immunization
Pharmaceutical Preparations/administration & dosage
Pharmaceutical Preparations/adverse effects*
Physician's Practice Patterns/trends
Physician-Patient Relations
Physicians
United States
Substances:
Contraceptives, Oral
Pharmaceutical Preparations
